These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 19514999)

  • 1. Protein adsorption and displacement at lipid layers determined by total internal reflection fluorescence (TIRF).
    Jorgensen L; Wood GK; Rosenkrands I; Petersen C; Christensen D
    J Liposome Res; 2009; 19(2):99-104. PubMed ID: 19514999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomes based on dimethyldioctadecylammonium promote a depot effect and enhance immunogenicity of soluble antigen.
    Henriksen-Lacey M; Bramwell VW; Christensen D; Agger EM; Andersen P; Perrie Y
    J Control Release; 2010 Mar; 142(2):180-6. PubMed ID: 19874860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of cationic liposome and niosome-based adjuvant systems for protein subunit vaccines: characterisation, environmental scanning electron microscopy and immunisation studies in mice.
    Vangala A; Kirby D; Rosenkrands I; Agger EM; Andersen P; Perrie Y
    J Pharm Pharmacol; 2006 Jun; 58(6):787-99. PubMed ID: 16734980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of trehalose 6,6'-diester (TDX) chain length on the physicochemical and immunopotentiating properties of DDA/TDX liposomes.
    Kallerup RS; Madsen CM; Schiøth ML; Franzyk H; Rose F; Christensen D; Korsholm KS; Foged C
    Eur J Pharm Biopharm; 2015 Feb; 90():80-9. PubMed ID: 25445301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6'-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responses.
    Davidsen J; Rosenkrands I; Christensen D; Vangala A; Kirby D; Perrie Y; Agger EM; Andersen P
    Biochim Biophys Acta; 2005 Dec; 1718(1-2):22-31. PubMed ID: 16321607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidating the mechanisms of protein antigen adsorption to the CAF/NAF liposomal vaccine adjuvant systems: effect of charge, fluidity and antigen-to-lipid ratio.
    Hamborg M; Rose F; Jorgensen L; Bjorklund K; Pedersen HB; Christensen D; Foged C
    Biochim Biophys Acta; 2014 Aug; 1838(8):2001-10. PubMed ID: 24769435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pegylation of DDA:TDB liposomal adjuvants reduces the vaccine depot effect and alters the Th1/Th2 immune responses.
    Kaur R; Bramwell VW; Kirby DJ; Perrie Y
    J Control Release; 2012 Feb; 158(1):72-7. PubMed ID: 22032883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein antigen adsorption to the DDA/TDB liposomal adjuvant: effect on protein structure, stability, and liposome physicochemical characteristics.
    Hamborg M; Jorgensen L; Bojsen AR; Christensen D; Foged C
    Pharm Res; 2013 Jan; 30(1):140-55. PubMed ID: 22956169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Th1 immune responses can be modulated by varying dimethyldioctadecylammonium and distearoyl-sn-glycero-3-phosphocholine content in liposomal adjuvants.
    Hussain MJ; Wilkinson A; Bramwell VW; Christensen D; Perrie Y
    J Pharm Pharmacol; 2014 Mar; 66(3):358-66. PubMed ID: 24251796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The vesicle size of DDA:TDB liposomal adjuvants plays a role in the cell-mediated immune response but has no significant effect on antibody production.
    Henriksen-Lacey M; Devitt A; Perrie Y
    J Control Release; 2011 Sep; 154(2):131-7. PubMed ID: 21640145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NIR transmission spectroscopy for rapid determination of lipid and lyoprotector content in liposomal vaccine adjuvant system CAF01.
    Christensen D; Allesø M; Rosenkrands I; Rantanen J; Foged C; Agger EM; Andersen P; Nielsen HM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):914-20. PubMed ID: 18694823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid conjugation of TLR7 agonist Resiquimod ensures co-delivery with the liposomal Cationic Adjuvant Formulation 01 (CAF01) but does not enhance immunopotentiation compared to non-conjugated Resiquimod+CAF01.
    Wilkinson A; Lattmann E; Roces CB; Pedersen GK; Christensen D; Perrie Y
    J Control Release; 2018 Dec; 291():1-10. PubMed ID: 30291987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes.
    Korsholm KS; Agger EM; Foged C; Christensen D; Dietrich J; Andersen CS; Geisler C; Andersen P
    Immunology; 2007 Jun; 121(2):216-26. PubMed ID: 17302734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trehalose preserves DDA/TDB liposomes and their adjuvant effect during freeze-drying.
    Christensen D; Foged C; Rosenkrands I; Nielsen HM; Andersen P; Agger EM
    Biochim Biophys Acta; 2007 Sep; 1768(9):2120-9. PubMed ID: 17555704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha,alpha'-trehalose 6,6'-dibehenate in non-phospholipid-based liposomes enables direct interaction with trehalose, offering stability during freeze-drying.
    Christensen D; Kirby D; Foged C; Agger EM; Andersen P; Perrie Y; Nielsen HM
    Biochim Biophys Acta; 2008 May; 1778(5):1365-73. PubMed ID: 18261458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A total internal-reflection technique for the examination of protein adsorption.
    Watkins RW; Robertson CR
    J Biomed Mater Res; 1977 Nov; 11(6):915-38. PubMed ID: 73542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The surface charge of liposomal adjuvants is decisive for their interactions with the Calu-3 and A549 airway epithelial cell culture models.
    Ingvarsson PT; Rasmussen IS; Viaene M; Irlik PJ; Nielsen HM; Foged C
    Eur J Pharm Biopharm; 2014 Aug; 87(3):480-8. PubMed ID: 24726978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subunit vaccines: distearoylphosphatidylcholine-based liposomes entrapping antigen offer a neutral alternative to dimethyldioctadecylammonium-based cationic liposomes as an adjuvant delivery system.
    McNeil SE; Rosenkrands I; Agger EM; Andersen P; Perrie Y
    J Pharm Sci; 2011 May; 100(5):1856-65. PubMed ID: 21374619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomes act as stronger sub-unit vaccine adjuvants when compared to microspheres.
    Kirby DJ; Rosenkrands I; Agger EM; Andersen P; Coombes AG; Perrie Y
    J Drug Target; 2008 Aug; 16(7):543-54. PubMed ID: 18686124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvants Based on Synthetic Mycobacterial Cord Factor Analogues: Biophysical Properties of Neat Glycolipids and Nanoself-Assemblies with DDA.
    Kallerup RS; Franzyk H; Schiøth ML; Justesen S; Martin-Bertelsen B; Rose F; Madsen CM; Christensen D; Korsholm KS; Yaghmur A; Foged C
    Mol Pharm; 2017 Jul; 14(7):2294-2306. PubMed ID: 28497975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.